This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Hypothyreosis and Thyroxine purchase for inclusion criteria
HYPOT_THYRO_INCL
No definition available.
Endpoint definition
↥
FinnGen phenotype data
429209 individuals
Apply sex-specific rule None
429209
Check conditions None
429209
Check pre-conditions, main-only, mode, registry filters
3 out of 7 registries used, show all original rules.
54714
Check minimum number of events
Min. number of events
3
54714
Remove individuals based on genotype QC
52943
HYPOT_THYRO_INCL
Control definitions
Controls for this endpoint are individuals that are not cases.
Extra metadata
First used in FinnGen datafreeze
DF8
Show upset plot detailing case counts by codes
Or the full data table
Similar endpoints
↥List of similar endpoints to
Hypothyreosis and Thyroxine purchase for inclusion criteria
based on the number of shared cases.
Broader endpoints:
- Disorders of the thyroid gland
- Used for control exclusion in common control thyroid runs
- Endocrine, nutritional and metabolic diseases
Narrower endpoints:
Summary Statistics
↥Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 52943 | 42200 | 10743 |
| Unadjusted prevalence (%) | 12.85 | 18.33 | 5.91 |
| Mean age at first event (years) | 51.49 | 49.75 | 58.29 |
Mortality
Not a core endpoint, no data to show.
Age distribution of first events
Year distribution of first events
Cumulative Incidence
Not a core endpoint, no data to show.
Correlations
↥
Index endpoint: HYPOT_THYRO_INCL – Hypothyreosis and Thyroxine purchase for inclusion criteria
GWS hits:
Survival analyses between endpoints
↥Not a core endpoint, no data to show.
Drugs most likely to be purchased after Hypothyreosis and Thyroxine purchase for inclusion criteria
↥Endpoint not on priority list, no data to show.